T0	KEYPHRASE-NOTYPES 24 42	major shortcomings
T1	KEYPHRASE-NOTYPES 60 74	available data
T2	KEYPHRASE-NOTYPES 76 89	Determination
T3	KEYPHRASE-NOTYPES 107 114	species
T4	KEYPHRASE-NOTYPES 137 145	isolates
T5	KEYPHRASE-NOTYPES 163 170	studies
T6	KEYPHRASE-NOTYPES 176 183	culture
T7	KEYPHRASE-NOTYPES 240 251	CSF samples
T8	KEYPHRASE-NOTYPES 291 305	synovial fluid
T9	KEYPHRASE-NOTYPES 309 323	tissue samples
T10	KEYPHRASE-NOTYPES 335 358	PCR-based amplification
T11	KEYPHRASE-NOTYPES 362 365	DNA
T12	KEYPHRASE-NOTYPES 389 405	tissue specimens
T13	KEYPHRASE-NOTYPES 430 441	sensitivity
T14	KEYPHRASE-NOTYPES 476 495	specific PCR target
T15	KEYPHRASE-NOTYPES 518 529	sensitivity
T16	KEYPHRASE-NOTYPES 547 550	CSF
T17	KEYPHRASE-NOTYPES 619 626	samples
T18	KEYPHRASE-NOTYPES 636 643	culture
T19	KEYPHRASE-NOTYPES 683 691	patients
T20	KEYPHRASE-NOTYPES 697 699	EM
T21	KEYPHRASE-NOTYPES 731 742	antibiotics
T22	KEYPHRASE-NOTYPES 744 757	determination
T23	KEYPHRASE-NOTYPES 775 782	species
T24	KEYPHRASE-NOTYPES 798 805	samples
T25	KEYPHRASE-NOTYPES 811 833	extracutaneous lesions
T26	KEYPHRASE-NOTYPES 853 860	results
T27	KEYPHRASE-NOTYPES 891 898	strains
T28	KEYPHRASE-NOTYPES 929 952	recognizable EM lesions
T29	KEYPHRASE-NOTYPES 954 959	Fewof
T30	KEYPHRASE-NOTYPES 966 973	studies
T31	KEYPHRASE-NOTYPES 1006 1023	major determinant
T32	KEYPHRASE-NOTYPES 1031 1042	probability
T33	KEYPHRASE-NOTYPES 1059 1068	infection
T34	KEYPHRASE-NOTYPES 1076 1094	particular species
T35	KEYPHRASE-NOTYPES 1119 1129	prevalence
T36	KEYPHRASE-NOTYPES 1133 1147	regional ticks
T37	KEYPHRASE-NOTYPES 1177 1184	results
T38	KEYPHRASE-NOTYPES 1238 1250	small number
T39	KEYPHRASE-NOTYPES 1254 1259	ticks
T40	KEYPHRASE-NOTYPES 1267 1280	human samples
T41	KEYPHRASE-NOTYPES 1307 1321	investigations
T42	KEYPHRASE-NOTYPES 1326 1334	addition
T43	KEYPHRASE-NOTYPES 1345 1358	human samples
T44	KEYPHRASE-NOTYPES 1381 1403	different time periods
T45	KEYPHRASE-NOTYPES 1411 1430	different locations
T46	KEYPHRASE-NOTYPES 1456 1469	consideration
T47	KEYPHRASE-NOTYPES 1514 1532	regional variation
T48	KEYPHRASE-NOTYPES 1540 1546	number
T49	KEYPHRASE-NOTYPES 1550 1564	infected ticks
T50	KEYPHRASE-NOTYPES 1573 1585	distribution
T51	KEYPHRASE-NOTYPES 1606 1611	ticks
T52	KEYPHRASE-NOTYPES 1642 1649	results
T53	KEYPHRASE-NOTYPES 1663 1664	B
T54	KEYPHRASE-NOTYPES 1666 1673	garinii
T55	KEYPHRASE-NOTYPES 1701 1705	skin
T56	KEYPHRASE-NOTYPES 1737 1740	CSF
T57	KEYPHRASE-NOTYPES 1758 1762	Note
T58	KEYPHRASE-NOTYPES 1778 1779	B
T59	KEYPHRASE-NOTYPES 1781 1798	afzelii infection
T60	KEYPHRASE-NOTYPES 1806 1820	nervous system
T61	KEYPHRASE-NOTYPES 1881 1905	typical clinical picture
T62	KEYPHRASE-NOTYPES 1909 1921	European LNB
T63	KEYPHRASE-NOTYPES 1938 1939	B
T64	KEYPHRASE-NOTYPES 1941 1958	garinii infection
T65	KEYPHRASE-NOTYPES 1967 1983	radiculoneuritis
T66	KEYPHRASE-NOTYPES 1991 2014	peripheral facial palsy
T67	KEYPHRASE-NOTYPES 2031 2040	detection
T68	KEYPHRASE-NOTYPES 2044 2045	B
T69	KEYPHRASE-NOTYPES 2047 2054	afzelii
T70	KEYPHRASE-NOTYPES 2058 2061	CSF
T71	KEYPHRASE-NOTYPES 2089 2109	nonspecific symptoms
T72	KEYPHRASE-NOTYPES 2127 2135	patients
T73	KEYPHRASE-NOTYPES 2147 2152	CSF B
T74	KEYPHRASE-NOTYPES 2154 2161	afzelii
T75	KEYPHRASE-NOTYPES 2200 2228	European diagnostic criteria
T76	KEYPHRASE-NOTYPES 2233 2236	LNB
